TREATMENT OF ACUTE LUNG INFLAMMATION BY PULMONARY DELIVERY OF ANTI-TNF-alpha SIRNA WITH PAMAM DENDRIMERS IN A MURINE MODEL - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Journal of Pharmaceutics and Biopharmaceutics Année : 2020

TREATMENT OF ACUTE LUNG INFLAMMATION BY PULMONARY DELIVERY OF ANTI-TNF-alpha SIRNA WITH PAMAM DENDRIMERS IN A MURINE MODEL

Résumé

To improve the efficacy of nucleic acid-based therapeutics, e.g., small interfering RNA (siRNA), transfection agents are needed for efficient delivery into cells. Several classes of dendrimers have been found useful as transfection agents for the delivery of siRNA because their surface can readily be functionalized, and the size of the dendriplexes they form with siRNA is within the range of conventional nanomedicine. In this study, commercially available generation 3 poly(amidoamine) (PAMAM) dendrimer was investigated for pulmonary delivery of siRNA directed against tumor necrosis factor (TNF) α for the treatment of acute lung inflammation. Delivery efficiency was assessed in vitro in the RAW264.7 macrophage cell line activated with lipopolysaccharide (LPS), and efficacy was evaluated in vivo in a murine model of LPS-induced lung inflammation upon pre-treatment with TNF-α siRNA. The PAMAM dendrimer-siRNA complexes (dendriplexes) displayed strong siRNA condensation and high cellular uptake in macrophages compared with non-complexed siRNA. Q-PCR analyses showed that the dendriplexes mediated efficient and specific TNF-α silencing in vitro, as compared to non-complexed siRNA and dendriplexes with negative control siRNA. Also in vivo, the PAMAM dendriplexes induced efficacious TNF-α siRNA inhibition, as compared to non-complexed siRNA, upon pulmonary administration to mice with LPS-induced lung inflammation. Hence, these data suggest that PAMAM dendrimers are promising for the local delivery of TNF-α siRNA in the treatment of lung inflammation via pulmonary administration.
Fichier principal
Vignette du fichier
Dendriplex2-PAMAM_R1_final.pdf (520.19 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-02997033 , version 1 (09-11-2020)

Identifiants

Citer

Adam Bohr, Nicolas Tsapis, Camilla Foged, Ilaria Andreana, Mingshi Yang, et al.. TREATMENT OF ACUTE LUNG INFLAMMATION BY PULMONARY DELIVERY OF ANTI-TNF-alpha SIRNA WITH PAMAM DENDRIMERS IN A MURINE MODEL. European Journal of Pharmaceutics and Biopharmaceutics, 2020, 156, pp.114-120. ⟨10.1016/j.ejpb.2020.08.009⟩. ⟨hal-02997033⟩
23 Consultations
70 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More